Christoph Hock

Schlieren, ZH 8952, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 79 publications

Independent and interactive contributions of white matter hyperintensities and Alzheimer's disease imaging and plasma biomarkers to cognitive decline in older adults without dementia.

Independent and interactive contributions of white matter hyperintensities and Alzheimer's disease imaging and plasma biomarkers to cognitive decline in older adults without dementia.

Journal: Alzheimer's research & therapy

Published: January 04, 2026

Cliramitug for depletion of cardiac amyloid transthyretin: long-term follow-up of the NI006-101 trial.

Cliramitug for depletion of cardiac amyloid transthyretin: long-term follow-up of the NI006-101 trial.

Journal: Nature medicine

Published: September 18, 2025

Increased levels of GFAP and purinergic P2X7 receptor in Alzheimer's disease brain are associated with Aβ, tau pathologies and synaptic loss.

Increased levels of GFAP and purinergic P2X7 receptor in Alzheimer's disease brain are associated with Aβ, tau pathologies and synaptic loss.

Journal: Alzheimer's research & therapy

Published: July 30, 2025

Predicting cognitive decline with amyloid-PET, plasma p-tau217, Aβ42/40, and p-tau217/Aβ42 in a community-based cohort - relevance for clinical trial enrollment.

Predicting cognitive decline with amyloid-PET, plasma p-tau217, Aβ42/40, and p-tau217/Aβ42 in a community-based cohort - relevance for clinical trial enrollment.

Journal: Alzheimer's & dementia : the journal of the Alzheimer's Association

Published: May 15, 2025

Hippocampal iron patterns in aging and mild cognitive impairment.

Hippocampal iron patterns in aging and mild cognitive impairment.

Journal: Frontiers in aging neuroscience

Published: March 24, 2025

Reduced synaptic vesicle protein 2A in extracellular vesicles and brains of Alzheimer's disease: associations with Aβ, tau, synaptic proteins and APOE ε4.

Reduced synaptic vesicle protein 2A in extracellular vesicles and brains of Alzheimer's disease: associations with Aβ, tau, synaptic proteins and APOE ε4.

Journal: Translational neurodegeneration

Published: March 07, 2025

Protective Effects of Socioeconomic Status and Lifestyle on Amyloid- and White Matter Hyperintensity-Related Longitudinal Brain Atrophy and Cognitive Decline.

Protective Effects of Socioeconomic Status and Lifestyle on Amyloid- and White Matter Hyperintensity-Related Longitudinal Brain Atrophy and Cognitive Decline.

Journal: Annals of neurology

Published: February 15, 2025

Voxel-wise insights into early Alzheimer's disease pathology progression: the association with APOE and memory decline.

Voxel-wise insights into early Alzheimer's disease pathology progression: the association with APOE and memory decline.

Journal: GeroScience

Published: October 30, 2024

Point of view: Challenges in implementation of new immunotherapies for Alzheimer's disease.

Point of view: Challenges in implementation of new immunotherapies for Alzheimer's disease.

Journal: The journal of prevention of Alzheimer's disease

Published: October 28, 2024

Altered T-cell reactivity in the early stages of Alzheimer's disease.

Altered T-cell reactivity in the early stages of Alzheimer's disease.

Journal: Brain : a journal of neurology

Published: August 21, 2024

Spiral volumetric optoacoustic tomography of reduced oxygen saturation in the spinal cord of M83 mouse model of Parkinson's disease.

Spiral volumetric optoacoustic tomography of reduced oxygen saturation in the spinal cord of M83 mouse model of Parkinson's disease.

Journal: European journal of nuclear medicine and molecular imaging

Published: June 25, 2024

Prediction of Cardiac ATTR Depletion by NI006 (ALXN2220) Using Mechanistic PK/PD Modeling.

Prediction of Cardiac ATTR Depletion by NI006 (ALXN2220) Using Mechanistic PK/PD Modeling.

Journal: Clinical pharmacology and therapeutics

Published: May 15, 2024

Showing 1-12 of 79

Last Updated: 09/26/2026